JenaValve Technology, Inc. has appointed Edward Sarnowski as Chief Technology Officer to lead its research and development efforts. This move follows the recent FDA approval of JenaValve's Trilogy Transcatheter Heart Valve System, designed to treat severe aortic regurgitation. Sarnowski brings over 20 years of experience in medical device R&D, particularly in structural heart and transcatheter valve technologies, and will focus on advancing the Trilogy platform and expanding its capabilities. The appointment signals JenaValve's commitment to innovation and growth as it commercializes its first-of-its-kind heart valve therapy in the U.S.
Zcash (ZEC) is approaching the $600 mark after breaking out of a multi-week consolidation, showing strong bullish momentum. The price has surpassed key moving averages and resistance levels, supported by healthy trading volume and positive technical ...
Ethereum is gaining strength, trading near $1,920 after surpassing its 26-day and 50-day EMAs, signaling renewed buying interest. The next key resistance is the 100-day EMA at around $1,944; a daily close above this could lead Ethereum toward the 200...
Bitcoin (BTC) is showing signs of recovery after a prolonged downtrend, breaking above its 26-day and 50-day exponential moving averages (EMAs) near $63,400 and $64,100 respectively. This technical rebound suggests strengthening short-term momentum a...
ETHSystems, a new Ethereum-focused non-profit backed by Bitmine Immersion Technologies and Ethereum co-founder Joe Lubin, aims to enhance privacy on the Ethereum network for institutional use. This marks the third non-profit stepping in as the Ethere...
Lockheed Martin Ventures, the $1 billion venture capital arm of Lockheed Martin, is expanding into the UK and Europe with a new London office. It plans to invest at least $100 million in defense technology startups to strengthen transatlantic defense...
